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CHAPTER – 1
INTRODUCTION
Oral Carcinomas are grouped under
1. Cheek
2. Buccoalveolar sulci
Buccal Mucosa 3. Retromolar
4. Lip  –  Upper,  Lower,  Angle  of  mouth 
(fissure)
Carcinoma Tongue anterior 2/3 
Carcinoma alveolus upper, lower
Carcinoma floor of mouth
Carcinoma palate.
Among  the  Carcinoma  of  oral  cavity  the  commonest  was 
Squomous  cell  Carcinoma.  The  majority  if  these  are  seen  in  very 
advanced stage and treatment of these conditions are very demanding 
with surgery and radiotherapy being the main modality of therapy.
The pathetic  way they come to hospital  is  a challenge to the 
surgeon, surgical team and hospital when attempts are made to solve 
this problem.
The incidence among oral cancers, association of risk factors, 
role of  primary radiotherapy,  palliative radiotherapy,  primary surgery 
and salvage surgery for advanced disease has been studied.
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AIM OF THE STUDY
• To find out the age group with highest incidence
• To find out the site of commonest presentation
• Association  of risk factors with oral cancers
• To find presenting stage at the time of hospital visit
• To assess the response of primary radiotherapy in all stages of 
disease
• To study role of primary surgery
• To study the role of salvage surgery and out come in advanced 
oral Carcinoma
• To  look  in  to  various  aspects  of  primary  reconstruction  for 
excisional defect in oral cancer.
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MATERIALS AND METHODS
All  patients  who reported at  cancer department diagnosed as 
oral cancer at Govt. Royapettah Hospital were included in the study.
The study period was eighteen months from Oct 2004 to Mar 
2006. No specific selection criteria was used among oral cancers.
The patients  either  came to  department  of  cancer  directly  or 
were referred from other departments and other hospitals after proving 
the malignancy by histopathological examination.
Diagnosis  was  confirmed  by  histopathological  examination  of 
specimen obtained by wedge biopsy of ulcer/growth.
Detailed  history  regarding  duration  of  symptoms  habits  like 
smoking / tobacco were obtained, baseline investigation done which 
included a complete hemogram, blood biochemistry,  X-raychest and 
X-ray mandible as required.
A through physical  examination was  done to  assess the size 
and extent of tumour, presence or absence of trismus, involvement of 
bone & skin. Nodal status assessed clinically.  All  patients assessed 
and stage in TNM staging.
The  protocol  followed  at  the  cancer  department  GRH  is  to 
subject  the patients  with  advanced disease to  primary  radiotherapy 
except  in  few  occasion  where  surgery  has  been  taken  as  primary 
modality of management.
Radiotherapy was given as external beam radio therapy using 
radioactive cobalt 60.
Dosage used was 6000 CGy
200 CGy / day for 5 days in a week for 5 – 7 weeks
Criteria for response
Complete  regression  of  tumour  and  nodes  was  taken  as 
excellent response while presence of residual lesion post radiotherapy 
was considered partial response.
Follow – up
Complete  regression  of  lesion  were  followed  up  with 
observation.
Residual  lesion  were  subject  to  SALVAGE SURGERY which 
included resection of tumour along with RND.
RND – Routinely performed in all cases which requires a block 
dissection.  Modified  criles  incision  was  used.  Flaps  raised  and 
dissection carried out. Sacrificing SCM, IJV and Spinal accessory N.
All  patients  underwent  primary  reconstructions  for  the  excisional 
defects.
The primary reconstruction carried out among the cases are
Primary suture
Split skin graft
Pectoralis major myocutaneous flap
Pectoralis major osseomyocutoneus flap
Fore head flap
Among  these  pectoral’s  major  myocutaneous  flap  was  used  in 
majority of cases for both inner lining and cover.
All  patients followed up two weeks later after surgery and once to 
twice in a month.
LIMITATIONS
i. There was a very high dropout rate even at the initial stage of study. 
some patients were not willing for salvage procedure after RT.
ii. Because of short period available, patients could be followed for a 
minimum period, only,  Hence adequate data regarding tumour free 
interval, survival period, exact recurrence rate were not available.
iii. Since most of the patient present with late stage of disease, proper 
evaluation of primary RT and salvage procedure in early,  stage of 
disease could not be studied.
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ANATOMY
The oral cavity includes buccal mucosal lining of inner aspect of 
cheeks, lips from contact of opposing lips to the line of attachment of 
upper and lower alveolar ridges, mucosal lines of alveolar process of 
maxilla  and  mandible,  palate,  sulci  of  both  jaws,  floor  of  mouth, 
tongue.
The mucous membrance of  mouth is  adherent  to the deeper 
structures, on lips and check to face nuscles, on tongue to the muscles 
thereof and on the hard plate to the periosteum of the bone. Mucous 
membranes of periosteum is strongly united with periosteum and the 
combined  layers  are  called  mucoperiosteum.  The  attachment  of 
periosteum to bone is secured by sharpey’s fibres. Over the horizontal 
plate  of  palatine  bone  mucus  membrane  and  periosteum  are 
separated  by  a  mass  of  mucous  gland  tissue.  It  is  covered  with 
stratified  Squomous epithelium and is  supplied  by trigeminal  nerve, 
above by maxillary nerve and below by mandibular nerve.
Tongue is essentially a mass of skeletal muscle mostly covered 
by mucous membrane. Main parts are dorsum, tip, inferior surface and 
root.  Anterior  2/3  of  tongue  (pre  sulcal)  is  covered  by  mucous 
membrane  into  which  underlying  muscles  are  inserted.  Surface 
epithelium is of stratified squamous epithelium and is roughened by 
presence of  many papillae.  No glands on dorsum of 2/3 of  tongue. 
Posterior third is really a part of pharynx but it is obviously (Post sulcal) 
convenient to study with it’s rest of organ as part of mouth. Between 
tongue and epiglottis is glossoepiglottic fold.
Separating the elastic  membrane of  oral  floor  and oral  cavity 
area is the mandible. The body of the mandible is covered by loose 
free gingival  mucosa.  The alveolar  ridge is  that  section holding the 
teeth  and  is  covered  by  the  attached  gingival  mucosa.  The  bond 
between the periosteum of alveolar ridges and specialized attached 
gingival  mucosa is necessary  for  wearing dentures.  Preservation of 
buccal sulcus, oral floor, preservation of chewing, provision of a base 
for dental appliances and preservation of normal appearing lower third 
of  face are all  essential  reasons for maintenance (or)  restoration of 
mandibular contour.
An understanding of the regional lymph node anatomy is critical 
to the case of head and neck cancer patients, there are several major 
lymphatic chains in the neck containing nearly 200 lymph nodes that 
run parallel to the jugular veins, spinal accessory Nerve and into the 
submandibular triangle.
To  facilitate  communication  regarding  cervical  node  anatomy 
various levels been described.
Level I - Includes  nodes  within  the  submental  and  
submandibular triangle
Level II - Includes nodes extending from subdigastric area to 
the carotid and nodes surrounding spinal accessory  N 
from jugular foramen to the posterior border  of 
sternocleidomastoid muscle.
Level Ill - Includes nodes principally along the jugular veins  
between  the carotid  and its  bifurcation,  posterior  
border  of  sterno  cleido  mastoid  muscle  and  
omohyoid.
Level IV - Includes nodes below omohyoid above the level of 
clavicle  between  carotid  vessels  anteriorly  and  
omohyoid posteriorly.
Level V - Includes nodes in the posterior cervical triangle.
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ETIOLOGY
TOBACCO
The  relation  between  tobacco  exposure  to  oral  mucosa  and 
disease development has been demonstrated strongly. A clear dose – 
response relationship  has been identified,  with  a  greater  risk  being 
directly  proportional  to  intensity  and duration of  exposure.  It  is  one 
among  the  independent  strong  risk  factors.  Risks  decreased  only 
gradually after cessation of tobacco, tobacco use was also linked with 
salivar gland tumours.
SMOKING
The  risk  of  malignancy  is  six  times  of  non-smokers. 
Approximately 90% of patients with cancer oral cavity smoke tobacco. 
Smoking  filter  Vs  non  filter  cigarettes  does  not  alter  risk,  while 
cessation of tobacco smoke use appears to reduce risk only gradually.
SMOKELESS TOBACCO
The risk of oral cancer was found to increase four times in use 
of  smokeless  tobacco.  In  India  and  other  parts  of  world,  the  habit 
exists  of  using dried and cured tobacco leaf,  betel  nut  or  quid and 
slaked lime. This mixture is highly irritant to oral mucosa. 
ALCOHOL
Alcohol is another strong independent risk factor for oral cancer 
with  a  multiplicative  effect  from  combined  exposure  with  tobacco. 
Although pure ethanol  has never been shown to be carcinogenic in 
laboratory experiments,  alcoholic  beverages are now recognized as 
been important actiological factors in the development of oral cancer. 
The exact mechanism by which alcohol may exert influence upon oral 
mucosa has received less attention. Indirectly vitamin deficiencies and 
poor detoxfying capability due to alcohol  – induced liver dysfunction 
may promote carcinogenesis.
DIET & NUTRITION
The  plummer  Vinson  syndrome  has  been  associated  with 
increased risk of oral malignancy. Recent studies suggest Vit A,C and 
carotenoids may be protective against epithelial cancers.
GENETIC
The over expression of  P53 gene in cancer of  oral  cavity has 
been correlated with smoking and drinking. The P53 gene may be used 
in the future as a potential tumour marker and may help in identifying 
patients who are at risk for cancer development.
The c-myc and erb B-1 oncogene have been associated with 
squomous  cell  Carcinoma  of  oral  cavity.  The  P53  gene  may  be 
involved in the initial stages of carcinogenesis and c-mye, erb B – and 
ECF – R gene may become activated in later stages.
VIRAL
Another  possible  etiologic  agent  for  carcinogenesis  is  human 
papilloma virus (HPV); an epitheliotrophic DNA virus.
SOLAR EXPOSURE
Exposure to sunlight has been implicated in Carcinoma of the 
lip.
DENTITION
Poor dentition may be associated with cancer of oral cavity.
PRE MALIGNANT LESIONS
LEUKOPLAKIA
The WHO defines leukoplakia as a while keratotic plaque that 
cannot be rubbed off and cannot be given another diagnostic name. 
Oralleukoplakia is the most precancerous lesion of oral cavity. 4% to 
18% of  oral  leukoplakia  eventually  transform into  invasive  cancers. 
Morphologic  characterstics  of  OLK  that  may  increase  the  risk  of 
malignant transformation are
- Red or erosive components
- Verrucous hyperplasia pattern
- Microscopic dysplasia
ERYTHROPLASIA
Is a clinical term that defines a red mucosal plaque that does not 
arise from an obvious mechanical or inflammatory cause. EP has been 
associated  with  an  even  greater  risk  of  malignancy  than  oral 
leukoplakia. EP is seen in 1% to 3% of OLK.
DYSPLASIA
Is a histologic term that describes varying degrees of abnormal 
epithelial changes.
VERRUCOUS HYPERPLASIA
Is  an  irreversible,  probably  premalignant  lesion  often 
histologically  indistinguishable  from verrucous  carcinoma,  that  is  an 
early from of that neoplasm.
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PATHOLOGY
Squamous cell Carcinoma was graded histologically in 1920 by 
Borders.
Well differentiated Carcinoma have minimal pleomorphism and 
few  mitoses  and  poorly  differentiated  cancers  have  extensive 
plemorphism minimal Keratinisation and frequent mitoses.
Oral cancer generally refers to squamous cell Carcinoma of oral 
mucosal origin, which accounts for more than 90% of all malignancies.
SQUAMOUS CELL CARCINOMA
More than 90% of cancers of oral cavity are SCC. Squamous 
cell Carcinoma is usually described an either exophytic or ulcerative or 
a mixture of both i.e. ulcer proliferative.
The  exophytic  type  is  less  common  and  carries  a  better 
prognosis.  It  has  more  superficial  involvement  and  a  slow  growth 
pattern.  Deep infiltration  of  sub mucosal  tissue occurs  in  advanced 
stages. This type of SCC commonly occurs on the lips.
The ulcerative type is seen as a graying ulcer with heaped up 
edges  and  bleeds  easily.  This  type  tends  to  deeply  infiltrate  and 
usually has a high histologic grade.
BASALOID SCC
Is an aggressive form of squamous cell Carcinoma.
VERRUCOUS CARCINOMA
Uncommon variant of SCC represent less than that of 5% of all 
oral  cancer.  It  is considered as a low grade malignancy.  Verrucous 
carcinoma rarely metastasises. Therefore, elective neck dissection is 
not warranted. Radiation induced anaplastic transformation has been 
reported in multiple studies.
REGIONAL METASTASIS
The most important factor in the prognosis of patients with SCC 
of the oral cavity is the status of cervival lymph nodes. The cure rate 
dramatically reduces by 50% by metastasing into cervical lymphnode. 
The occult metastatic rate is 10% and is near 20% for stage II disease.
DISTANT METASTASIS
Squamous cell carcinoma of the head and neck tends to remain 
localized  for  a  period  of  time  at  the  primary  site  and  regional 
lymphnodes.  Distant  metastasis  eventually  occurs  in  15  –  20%  of 
patients with oral cancers.
The presence of advanced disease and failure at  the primary 
site and neck after therapy are often associated with a high risk of 
distant metastasis.
The most common site of distant metastasis is the lung, followed 
by the liver and bone. As a result of current therapies excellent Loco 
regional  control  of  disease  is  being  achieved.  However,  a  general 
trend  toward  an  increasing  number  of  distant  metastasis  is  being 
manifested. Effective modes of systemic chemotherapy are currently 
being developed to address this problem.
HPE OF SQUAMOUS CELL CA
FNAC OF SQUAMOUS CELL CA
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CLINICAL FEATURES & DIAGNOSIS
The commonly presenting age group is around 4 th & 5th decade 
with strong association of tobacco, alcohol and smoking and presents 
with either ulcer or growth or ulcero proliferative growth over the site of 
affection. Pain is a late feature. Excessive salivation, ankyloglossia are 
associated with ca tongue.  Dribbling of  saliva is associated with ca 
angle of mouth. 
DIAGNOSIS
I In experienced hands the application of TOLUIDINE BLUE DYE 
can be a useful  tool.  The sensitivity  is  about  90  –  95% and 
specificity is around 75 – 90% in extremely high risk population.
II Exfoliative  cytology  is  studied  in  various  groups  but  it  is  not 
substitute for an adequate biopsy.
III BIOPSY – The role of biopsy plays a main diagnostic tool in  
oral Malignancy.
Bioopsy may be - Punch Biopsy
- Wedge Biopsy
- Excisional Biopsy (< 1cm lesion)
IV CT Scan and MRI scan
Imaging techniques have improved the accuracy of staging but 
cannot determine if nodal enlargement is due to reactive changes or 
malignant involvement.
Both lacks sufficient sensitivity and specificity to replace elective 
neck dissection for both staging and prognostic purposes.
V Routine  hemogram,  chest  radiography,  ultra  sonogram 
abdomen (in selective cases) and LFT Selective cases)
VI DENTAL CONSULTATION
VII LARYNGOSCOPY,  BRONCHOSCOPY  and  ESOPHA-
GOSCOPY for  more accurate assessment  in  certain  cases and for 
presence of another primary.
T2 N0 M0 – CA CHEEK
T4 N1 M0 – CA CHEEK
T2 N1 M0 – CA CHEEK
T4 N1 M0 – CHEEK
T4 N2 M0 – CA CHEEK
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STAGING AND SCREENING
TNM staging system is a clinical staging system that allows to 
design treatment modality, compare results and assess prognosis.
PRIMARY TUMOUR (T)
Tx - Primary tumour cannot be assessed
To - No evidence of primary tumour
Tis - Carcinoma in situ
T1 - Tumour not more than 2cm in greatest dimension
T2 - Tumour  more  than  2cm  and  not  more  than  4cm  in  
greatment dimension
T3 - Tumour more than 4 cm in greatest dimension
T4 - Tumour invades adjacent structures
(Skin, bone and deep muscles)
NODAL INVOLVEMENT
Nx - Nodal status cannot be assessed
No - No regional lymph node
N1 - Presence of single lpsilateral lymph node not more than 3 
Cms in greatest dimension
N2 - N2a single lpsilateral lymph node more than 3 Cms but 
not more than 6 Cms in greatest dimension.
N2b Multiple ipsilateral lymph nodes not more than 6 
Cms in greatest dimension
N2c Bilateral / contralateral lymph node not more 
than 6 Cms in greatest dimension
N3 - Lymph nodes on any side more than 6 Cm in greatest  
dimension
DISTANT METASTASIS 
Mx - Distant Metastasis not assessed
Mo - No distant metastasis
M1 - Presence of distant metastasis
Stage Grouping
Stage I T1 No Mo
Stage II T2 No Mo
Stage III T3 No Mo
T1-3 N1 Mo
Stage IV T4 No-1 Mo
Any T N2-3 Mo
Any T Any N M1
LIMITATION OF TNM STAGING 
Tumour
Assessment  of  extent  of  primary  can  be  different  for  istance 
distinguishing a T1 VS T4 is relatively easy. However it may be difficult if 
a 3Cm cancer near retromandibular regn has a mandibular invasion.
Invasion into FOM musculature can also be difficult to asses and 
again cause difficulty in distinguishing T2 VS T4 disease.
NODE
Important prognostic factor such as fixation of nodes and level of 
nodal status not included. False negative physical examination varies 
from 16 – 60%.
SCREENING
The  most  extensively  studied  screening  procedure  has  been 
oral exfoliative cytology which has been recommended by American 
Dental  Association.  A high proportion of  false negative examination 
have been reported with this procedure.
Another  screening  method used frequently  has  been toludine 
blue  staining  of  aerodigestive  mucosa.  Toludine  blue  is  a 
metachromatic  nuclear  stain  that  is  taken  up  by  dysplastic  and 
cancerous epithelium. False positive results are around 9% and false 
negative  result around 5%.
Standardized  physical  examinations  is  the  best  means  of 
detecting lesion of the upper aerodigestive tract.
PREDICTORS OF NODAL DISEASE
TUMOUR THICKNESS
There is an association between thickness of  primary tumour 
and incidence of nodal metastasis. 
DIFFERENTIATION
There is a direct correlation between grade of primary tumour 
and cervical node metastasis.
VASCULAR & PERINEURAL INVASION 
Regional node metastasis was significantly increased in patients 
with perineural spread.
PROGNOSTIC EVALUATION
This is mainly based on clinical  staging of  tumour.  Prognosis 
can  be  predicted  by  various  histologic,  molecular  and  cellular 
characteristics of primary tumour and lymphnodes.
CYTOMORPHOMETRIC PARAMETERS
Morphologic methods such as size, volume cell number and cell 
morphology are objective measurement of tumour characteristic. A few 
reports  indicate a poor  prognosis  for  oral  premalignant  lesions with 
increased nuclear size and alteration in nuclear morphology.
CELLULAR PROLIFERATION
A  rapid  growth  rate  is  associated  with  poor  prognosis.  An  ↑ 
expression  of  structures  such  as  K1-67  antigen  and  EGF-R  are 
associated with proliferation at invading tumor margin. The EGF-R has 
been shown to be present primarily in poorly differentiated cells.
GENETIC 
Abnormalities  in  DNA-Mutation  and  detection  are  involved  in 
uncontrolled tumour growth.
C-myc  oncogenic  amplification  H-ras  and  C-myc  messenger 
RNA have been observed in less differentiated cells at the invasive 
margin of the tumour.
CELL SURFACE CARBOHYDRATE
Loss  of  expression  of  deletion  of  H  antigen  on  cell  are 
associated with presence of metastasis.
NODAL CHARACTERISTICS
Positive  nodes  are  associated  with  poor  prognosis  when 
compared with negative node.
Multiple  nodal  metastasis  carries  worse  prognosis  than 
involvement of single node metastasis.
Fixation is not included in TNM staging.
Extranodal  spread  is  associated  with  50%  reduction  survival 
when compared with nodes without ENS.
Patients with level 4 & 5 involvement have a worse prognosis.
Nodes with lymphocyte predominant pattern is qassociated with 
a good prognosis.
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PRINCIPLES OF RADIOTHERAPY
Cancers  of  the  oral  cavity  are  of  particular  importance  to 
radiation oncologist. They have an active role in early and advanced 
disease. The twin advantage is easy accessibility by External  beam 
(XRT) and brachy therapy as well as tolerance of normal tissue.
INDICATORS
• Tumour Control
Particularly small tumour T1 – T2 are equally well controlled by 
radiotherapy or surgery.
• Pre Surgical 
A dose of 50 Gy is delivered to the primary tumour and regional 
nodes  with  double  aim to  reduce the tumour  size  and to  kill 
tumour cells that are likely to be spilled during surgery.
Disadvantage
Wound healing – delayed due to fibrosis, infection
Assessment of tumour margin will be difficult during surgery.
• Post Surgical
In complete resection (upto 60 – 70 Gy dose given depending 
upon stage and grade of tumour.
When  elective  neck  dissection  is  first  choice,  RT  given 
depending upon histological grade.
Adv : 1. Sterilization of residual microscopic cells
2. Better assessment of tumour margin
Dis : Surgical  complication  may  delay  induction  of 
Radiotherapy.
Elective treatment of clinically negative nodes
If  a high rate of relapse is expected in the neck nodes, more 
than 90% of cases can be prevented by delivering 40 – 50 Gy to the 
neck.
Relapsing tumour after surgery
When salvage surgery is not feasible, salvage radiation therapy 
can be tried, although often with poor outcome due to tumour load, 
poor vascularisation and patients general condition.
Palliation
When tumour is condisered surgically (or) radio therapeutically 
incurable a few high dose fraction are given in order to  ↓ symptoms 
such as pain & bleeding.
TECHNIQUES OF RADIO THERAPY
EXTERNAL BEAM RADIOTHERAPY (XRT)
XRT as sole treatment with curative intent
70 -75 Gy to the tumour, 65 – 70 Gy to clinically positive nodes, 
elective neck node irradiation 45 – 50 Gy.
XRT with brachy therapy
XRT to tumour and primary nodes is started upto a dose of  
45 – 50 Gy followed by an interstitial implant (1 – 2 week later) with 
iridium wires delivering dose 25 – 30 Gy.
XRT followed by surgery
50G are given to tumour site and neck nodes.
XRT after surgery
When the local resection is sufficient no post op radiation given 
except  in  T4 where  a  dose  of  60  Gy  reduces  the  risk  of  local 
recurrence.
When there are positive nodes 50 Gy is sufficient to control the 
neck but may be increased to Gy when there is capsular rupture or 
perineural spread or tumour spillage is suspected.
Advantage of XRT
Centripetal shrinkage of tumour
Sterilises lymphatics
Allows adequate clearance
In advanced posteriorly placed tumour or illdefined primary that 
would make surgical exposure difficult, functional disability (speech / 
deglutition) is less.
Disadvantage
Tumour  that  have  deep  invasion  or  large  (T3 T4)  are  less 
responsive to XRT.
Second course XRT cannot be considered.
Salvage  surgery  for  radiation  failure  is  associated  with  low 
survival and high morbidity.
Side  effects  of  irradiation  like  Xerostomia,  mucositis  and 
osteoradionecrosis.
BRACHY THERAPY
Indication 
Well defined and accessible T1 & T2 tumour
Advantage
Conservative treatment
Well defined volume
SIDE EFFECTS OF RADIOTHERAPY
Acute
- Mucositis
- Dry mouth
- Loss of taste
- Dysphagia or dyspnoea
- Erythema & Epidermolysis
Late
- Soft tissue necrosis
- Osteroradionecrosis of mandible
predisposed by
o Dose delivered to maindible
o Mandibular  parts  not  covered  by 
healthy mucous
o Dental  extraction  within  10  days  of 
brachy therapy
- Hypothyroidism
RADIOTHERAPY UNIT
PT. RECEIVING RADIOTHERAPY
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PRINCIPLES OF SURGERY
Early  stage  disease  T1 –  T2 can  be  managed  either  by 
radiotherapy or surgery to give equally good results. Advanced lesion 
need a combination of both radiotherapy and surgery with or without 
chemotherapy.
Nodes larger  than 3 cms, nodes with  capsular  infiltration and 
multiple metastatic nodes need multimodality treatment.
When  combination  of  surgery  or  radiotherapy  is  used,  either 
could be tried first depending on the philosophy of treating  institution.
Margins of surgical resection vary from site tosite. +ve surgical 
margin  carries  poor  prognosis  and  should  be  avoided  by  frozen 
section histopathology of close or doubtful margin.
Primary reconstruction of surgical defects with well vascularised 
flaps should be done in most cases. This allows prompt healing, early 
resumption, effective rehabilitation and shorter hospital stay,
Appropriate corrective pre operative preparation is necessary.
Pre operative thought and planning in detail is required to help 
to overcome post surgical deficiencies.
Advantages
• Many cancers of oral cavity are amanable to surgical excision 
perorally.
• Surgical treatment is preferred in patients with advanced tumour 
and those with mandibular invasion.
• Requires less time & provides fewer longterm sequelae.
Disadvantage
• Potential risk of anaesthesia
• Functional disabilities
• Cost
Available surgical procedures for primary
• Wide excision
• Composite oral resection
• Composite oral resection with hemimandibulectomy
• Maxillectomy
• Hemiglossectomy
Mandible
Oral  cavity  cancers  are  often  about  to  involve  mandible. 
Invasion of mandible is not radiocurable and can spread perinerally via 
inferior alveolar nerve. CT is the preferred adjunctive diagnostic test 
for mandibular involvement. In these cases composite resection is the 
procedure of choice.
Direct  invasion  requires  hemimandibulectomy,  tumour 
approaching but not invading needs marginal mandibulectomy.
CERVICAL NODE METASTASIS
RADICAL NECK DISSECTION
Here  internal  jugular  vein,  spinal  accessory  nerve,  and 
sternomastoid are resected along with lymphatics in neck. The carotid 
artery,  phrenic,  vagus,  sympathetic  trunk,  hypoglossal  and  lingual 
nerve are preserved.
RND is  contra  indicated  in  presence  of  uncontrolled  primary, 
distant metastasis and fixed nodes.
MODIFIED NECK DISSECTION
Which could be
• Functional neck dissection 
• Selective neck dissection
Submandibular dissection
Suprahyoid dissection
Anterior neck dissection
Posterior neck dissection
• Extended neck dissection / Supra omohyoid
Prophylactic  neck  dissection  is  indicated  in  places  where 
primary is in one of the biologically aggressive site
i.e. Tongue
FOM
Alveolus
Soft palate
COMPOSITE RESECTION
COMPOSITE RESECTION
NECK DISSECTION
NECK DISSECTION 
MODIFIED CRILE’S INCISION FOR NECK DISSECTION
PMMC FLAP
PMMC – IMMEDIATE POST - OP
PMMC – LATE POST - OP
CHAPTER – 11
PRINCIPLES OF CHEMOTHERAPY
For an advanced Loco regional disease combination modality is 
useful Role of chemotherapy is as follows.
I. Palliative - in recurrent cases after surgery and / or 
radiotherapy
II. Previously untreated cases
Neo adjuvant chemotherapy
Adjuvant chemotherapy
Concurrent chemotherapy
Commonly used drugs are :
Response rate
Metho trexate 31%
Bleomycin 21%
Cisplatinum 28%
5FU 15%
Paclitaxel 38%
Docetaxel 38%
Carboplatin 22%
Ifosfamide 26%
It can be infused (or) perfused locally, infusion after ligation of 
external carotid. A beyond superior thyroid A to avoid eddy current & 
thrombus formation.
Role of chemotherapy in oral cancer is still evolving and seems 
promising.
CHAPTER – 12
RECONSTRUCTION
The object of reconstruction is to restore the form and function in 
the least possible time and in most economic manner.
The reconstruction  of  the  post  excisional  defect  in  the  same 
sitting is the rule, except when there is doubt about the adequacy of 
resection  or  general  condition  of  patient  does  not  permit  extended 
surgery.
All  post  excisional  wound  must  be  provided  with  immediate 
cover. Such a cover may be provided by
• Primary closure
• Split skin graft
• Local graft
• Skin and other tissue brought from distant site 
• Free flap micro vascular anastomosis
SPLIT SKIN GRAFT
Several problems are associated with the use of split thickness 
graft. Although they remain moist, they aways appear white because 
of desquomation. They cannot fill the cavity or cover the exposed bone 
or irradiated bed and they may contract.  This is excellent procedure 
where bed is suitable.
FULL THICKNESS GRAFT
In  areas  where  contraction  is  undesirable  full  thickness  graft 
may be useful.  A hairless donor  site should be selected to prevent 
intra oral hair growth.
MUCOUS MEMBRANE GRAFT
Mucous  membrane  is  the  tissue  of  choice  if  free  graft  are 
indicated but rarely is enough, available to be of practical value.
LOCAL FLAPS
They are readily available in operative field and are not subject 
to mary of the problems of the graft.
• Forehead flap
M. Narayanan used bipolar flaps
• Sternomastoid myocutaneous flap
• Tropezius flap
• Platysma myocutaneous flap
• Tongue flaps
• Naso labial flap
REGIONAL ARTERIALIZED FLAPS
These can provide tissue with a robust blood supply from non 
radiated  site  to  fill  the  defect  without  the  need  of  micro  vascular 
anastomosis.
Deltopectoral flap
Latissmus myocutaneous flap
Pectoralis major myocutaneous flap
FREE FLAPS
Recent  advances  and  refinements  in  micro  vascular  surgery 
have enabled reconstructive surgeons to transfer composite section of 
tissue  to  distant  site  in  single  operative  procedure  when  indicated. 
Three free tissue transfers can supply vascularised external cover with 
vascularised bone and internal lining of skin or mucosa to restore the 
pre operative functional anatomic unit and aesthetics to the patient.
• Free jejunal transfer
• Free osteocutaneous groin flap
• Radial forearm flap (Chinese flap)
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REVIEW OF LITERATURE
More than 100 000 cases of  oral  cancer occur every year  in 
South and South-East Asia, with poor prospect of survival : about 90% 
of these cases are attributable to smoking and chewing habits.-1   It is 
also encouraging that overall rates in India are  showing a decreasing 
trend  in  successive  birth  cohorts,  particularly  among  females  for 
intraoral  sites  other  than  tongue  (ICD9  143-145),  where  a   mean 
percentage  fall  of  16.8%  has  occurred  between  1975  and  1988, 
although rates remain in the high range of 1015/100 000 per annum. In 
Mumbai (Bombay), the incidence of tongue cancer was high : it was 
14.9/100  000  per  annum  (aged  3074,  standardized  to  the  world 
population) for men and 5.4 for women, but both values showed a fall, 
of  12.0  and  16.8%  respectively,  between  1975  and  1988.2 
Unfortunately,  it  cannot  be  assumed  that  these  trends  apply 
nationwide and there is growing concern that commercial areca nut 
and tobacco products will contribute to future rises in the incidence of 
oral submucous fibrosis and of oral cancer.3 Furthermore, decreases 
in  the  prevalence  of  traditional  pan-chewing  habits  in  the  more 
sophisticated  urban  areas  are  more  than  matched  by  increases  in 
smoking.
There is absolutely no doubt that on a global scale the use and 
abuse of tobacco products is the major cause of oral cancer.4,5 Alcohol 
us  synergizes with  tobacco as a risk factor  for  upper  aerodigestive 
tract  SCCs  :  this  synergism  is  super-multiplicative  for  the  mouth, 
additive for the larynx and between additive and multiplicative for the 
oesophagus.6 Sorting out the independent effects is difficult, however, 
because  these  habits  usually  overlap.  Many  believe  that  the  rising 
incidence of oral cancer in Europe and elsewhere in the Western world 
is largely due to increasing alcohol consumption. In many developing 
countries, particularly in the Islamic world and in Moslem communities 
every where, accurate data on alcohol consumption are impossible to 
obtain because of religious and cultural inhibitions. 
Evidence from case-control studies
The carcinogenicity of pan/betel quid mixtures has been clearly 
established in a meta-analysis of 17 pubilshed studies by Thomas and 
Wilson.7 These show a range of relative risks (RRs) averaging around 
10. However,  as pointed out by Warnakulasuriya,8 only four studies 
differentially examine the role of betel quid with and without tobacco, 
and with or without smoking, in cases of oral cancer in South Asian 
populations. It is clear that tobacco is the major carginogen, possibly 
partly  because  its  presence  adds  to  the  compulsion  to  chew more 
frequently. 
Evidence from prospective studies
Gupta et al.9 followed up 30 000 individuals more followed up 
over a 10-year period in three areas of India. In Ernakulum the annual 
age-adjusted incidence of oral cancer was 23/100 000 among betel 
quid-tobacco  chewers  compared  with  zero  in  smokers  and  non-
habitues : this is the most extensive study of its kind reported. 
The most comprehensive source of evidence remains the IARC 
publication of 1986.10 This evidence is also summarized  by the US 
Surgeon-General’s Report of 1989 which lists attributable risk (AR) for 
cancer at various sites  : the upper aerodigestive sites with which we 
are here concerned have the highest ARs, in males, of all the many 
sites for which smoking has been identified as playing a role. 
Beedi (bidi) smoking, as practised in the Indian sub-continent, is 
more hazardous  than cigarette  smoking.11  Mashberg and Meyers12 
reported  in  a  US  population  in  1976that  201  of  207  (90%) 
asymptomatic primarily erythroplastic carcinomas were in 3 locations 
floor of mouth, ventral or lateral tongue and soft palate complex. In the 
Amsterdam  series13 the  floor  of  mouth  and  retromolar  area  were 
significantly  more related  to  tobacco  use than  were  cancers  of  the 
tongue and cheek.
Over 300 carcinogens have been identified in tobacco smoke or 
in its water –soluble components which can be expected to leach into 
saliva.14 
In  has  been  known  since  the  1920s  that  polycyclic  aromatic 
hydrocarbons (PAHs) were the carcinogenic  agents  present  in  tars, 
and  this  lies  behind  the  tobacco  industry’s  promotion  of  ‘low  tar’ 
smoking  materials, while continuing  to promote ‘full strength’ brands. 
Benzo(a) pyrene is a powerful carcinogen and is found in amounts of 
20-40  ng  per  cigarette.  The  role  of  N-nitrosamines  is  reviewed  by 
Hoffman and Hecht. 
Polymorphisms of the p450 and GST genes are currently under 
active study in the search for genetic markers of susceptibility to head 
and neck cancer, and indeed to tobacco-related cancers at many other 
body sites.15,16 
Recreational  users  of  marijuana often  also enjoy  alcohol  and 
tobacco, and tobacco usually forms part of the marijuana smoking mix. 
Pure  Alcohol  and  oral  cancer  pure  ethanol  has  never  been 
shown to be carcinogenic in vitro or in animal studies.17,18
Nevertheless,  some  cohort  and  case  –  control  studies  have 
found an increased risk of upper aerodigestive tract cancer associated 
with alcohol drinking in nonsmokers.19
In  many  parts  of  the  Indian  subcontinent,  for  example,  local 
brews distilled from palm juice, ‘toddy’, are widely available particularly 
in rural areas where tobacco habitues may be unable to afford factory 
made (and therefore quality- controlled) beverages, whether they be of 
national origin or imported. Recent studies in South India demonstrate 
a clear role for alcohol.
There  are several ways in which alcohol is thought to contribute 
to head and neck cancer,  by both local  and systemic mechanisms. 
The IARC Monograph deals comprehensively with the evidence up to 
the late 1980s.17 The mechanisms are as follows:
• There  is  now  clear  evidence  that  ethanol  increases  the 
permeability   of  oral  mucosa  to  water  itself22,23 and  to  many 
water-soluble  molecules,  probably  including  important 
carcinogens : indeed,  increased passage of  nitrosonornicotine 
has been demonstrated in in vitro experiments.24,25 The effect is 
greater at 15% than at 5%, but is not further enhanced at 40% 
ethanol, suggesting the epithelial permeability barrier rather than 
to lipid extraction.26,27 This means that there will  be increased 
uptake  of  alcohol  itself,  and  of  carcinogens,  with  enhanced 
systemic effects. It also implies a solvent action of ethanol on 
keratinocyte  membranes  with  likely  enhanced  penetration  of 
carcinogens  into  proliferating  cells  where  they  may  exert  a 
direct mutagenic action.28 A dehydrating effect may contribute.29 
Recent animal experiments in which rats were fed ethanol  by 
stomach tube showed an indirect effect on the permeability of 
the  oral  mucosa,  because  there  was  decreased  synthesis  of 
lipids  contributing  to  the  intercellular  permeability  barrier, 
perhaps because of liver damage.30
• The immediate metabolite of ethanol  is acetaldeyde.  Some of 
thism  ay  be  formed  locally  and  damage  cells.31 Indeed 
considerable amounts of  acetaldehyde can be found in saliva 
after  moderate  alcohol  consumption,  owing  to  the  action  of 
bacterial  alcohol  dehydrogenases.32 Production  is  signifciantly 
reduced  after  three  days’  use  of  an  antiseptic  mouthwash 
(chlorhexidine),  perhaps  helping  to  explain  why  poor  oral 
hygiene appears to be an independent risk factor for oral cancer 
in some studies.33-35 Those genetically predisposed to be more 
rapid acetylators have been demonstrated to be at increase risk 
in one recent US study. 
• Alcoholic  liver  disease is  common in  heavy drinkers  and this 
reduces the detoxification of active carcinogens.19
• Alcohol is high in calories, which suppresses appetite in heavy 
drinkers. Those with a serious drinking problem become socially 
fractured, and many choose to spend available cash on drink 
rather  than  food.  All  of  this  contributes  to  inadequate  diet. 
Metabolism  is  further  damaged  by  liver  disease.  As  a  result 
nutritional deficiencies are common,36 and, as discussed below, 
these contribute significantly to lowered resistance to cancer.19
Unsurprisingly, therefore, alcoholic patients are at especial risk 
for head and neck cancer,  particularly at sites in direct contact with 
alcohol.37
Conversely,  ‘high-risk’  HPV  types  are  those  associated  with 
premalignant lesions and squamous cell carcinomas – again, most of 
the evidence coming from anogenital lesions. Among these HPVs 16, 
18,  31,  33,  35  and  39  are  found  most  commonly.38-40 Their  viral 
genomes  can  become  integrated  and  transcriptionally  active  in 
tumours and tumour cell lines, such that the IARC has classified HPV 
16 and 18 as carcinogenic in humans (group 1), HPV  31 and 33 as 
probably  carcinogenic  in  humans  (group  2a)  and  some  others  as 
possibly carcinogenic in humans (group 2b); the latest evaluations can 
be found at  the IARC Homepage (http://www.iarc/fr/).  Nevertheless, 
even the high-risk HPVs do not appear to be directly carcinogenic, but 
seem to require additional modifications of host – cell genes, brought 
about by physical or chemical carcinogens or other viral infections.40,41
The E6 and E7 ORFs of the high –risk HPVs are particularly 
important because they encode transforming proteins, and can thus be 
regarded as viral oncogenes, They are though to act by binding to and 
inactivating,  the  important  cell-cycles  regulatory  tumour  suppressor 
gene proteins p53 and pRb, respectively.42
Papilloma viruses and oral cancer
HPV 16 is the most common type to be associated with both 
cervical and oral cancers.43,45 In vitro studies show that primary human 
oral  epithelial  cells can be immortalized by high-risk HPV types;44,46 
however,  exposure to tobacco – related chemicals was required for 
these cells to progress to a fully malignant phenotype.47,48
CHAPTER - 14
OBSERVATIONS & DISCUSSION
A total of 104 patients were treated at the oncology department 
of Govt. Royapettah Hospital from Oct 2004 to Mar 2006.
The table below shows age wise & sex wise distribution of oral 
cavity cancer.
TABLE - 1
Age Males Females Total
30 - 40 12 4 16
41 - 50 24 10 34
51 - 60 20 14 34
61 - 70 10 6 16
71 - 80 2 1 3
80 - 90 1 0 1
Age and Sex Distribution of Oral Cancer
0
5
10
15
20
25
30
30 - 40 41 - 50 51 - 60 61 - 70 71 - 80 80 - 90
Males
Females
The highest incidence of oral cavity cancer occurred during 5th & 
6th decades of life constituting 68% of cases.
A definite male predominance was noticed, 63% of them were 
males.
TABLE – 2
Site of lesion No. of patients
Cheek 46
Tongue 35
Alveolus 15
Floor of Mouth 4
Lips 2
Soft Palate 2
Site of Lesion
Cheek
Tongue
Alveolus
Floor of mouth
Lips
Soft Palate
The  commonest  site  of  oral  cavity  cancer  was  cheek,  then 
cancer tongue.
TABLE - 3
Primary Lesion Nodal Status Metastasis
T0 - N0 22 M0 104
T1 5 N1 24 M1 -
T2 12 N2A 15
T3 29 N2B 20
T4 58 N2C 12
N3 11
Majority of patients presented with advanced disease. Maximum 
numbers in T4 & N2  groups (T4 – 55%, N2 – 45%). There is a strong 
association  with  risk  factors  in Ca oral  cavity.  95% of  cases of  Ca 
check is associated with  Tobaco chewing with or  without  betel  nut, 
80% of  Ca tongue cases is associated with  tobacco chewing  with 
betel nut.
TABLE - 4
Site Primary RT Palliative RT
Cheek 20 10
Alveolus - 4
Tongue 9 8
Lip - 1
Soft palate 1 1
Floor of Mouth - 2
The response to RT was excellent in T1 & T2 disease. Response 
was not good in late disease. Pall RT was given in 26 patients.
17 patients were taken for primary surgery. 
TABLE – 5
Wide Excision 7
Composite Resection 10
TABLE – 6
Procedure of 
Reconstruction
No. of cases
PMMC 9
Oral Flap 4
Nasolabial Flap 1
SSG 3
Salvage surgery was done in 10 patients.
CHAPTER - 15
RESULTS, SUMMARY & CONCLUSIONS
104 patients were treated for oral cavity cancer at Department of 
Oncology  Govt. Royapettah Hospital, from Oct 2004 to Mar 2006.
Highest  incidence  was  seen  at  5th &  6th decades  of  life  and 
majority of them were males. Cheek is the site commonly involved  
(45%), next comes tongue.
There  is  a  strong  association  of  the  risk  factor  of  Tobacco 
chewing with Ca cheek (95%).
Majority of patients presented with advanced disease. Maximum 
numbers in T4 & N2 groups (T4 – 55%, N2 – 45%). 
30 patients completed primary RT apy, 26 patients underwent 
palliative radiotherapy.  31 patients discontinued treatment at various 
stages.
17 patients were taken up for primary surgery.
10 patients were taken for salvage surgery.
Action  is  required  to  encourage  screening  programmes while 
raising awareness of oral cancer among public and association with 
risk factors.
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PROFORMA
Name :
Age :
Sex :
Reg. No. :
Dt. of Admission :
Dt. of Discharge :
Risk Factors :
Symtpoms :
Site :
Type :
HPE No :
HPE Report :
Staging :
Primary Radiotherapy :
Outcome :
Surgery :
Reconstruction :
Palliative Radiotherapy :
ABBREVIATIONS
A – Alcohol
AA – Alveolus
B – Betelnut Chewing
C – Cheek
CR - Composite resection 
DRX – Dropped at various level
E – Excision
FOM – Floor of Mouth
IJV – Internal Jugular Vein
L – Lip
LFT – Liver function tests
OLK – Oral leukoplakia 
PAL. RT – Palliative radiotherapy
Pmmc – Pect oralis Major myocutaneous flap
RND – Radical Neck Dissection
RT – Primary Radiotherapy W.E. – Wide Excision
S – Smoking
SCC – Squamous cell carcinoma 
SCM – Sternocleidomastoid
T (Risk factor) – Tobaccochewing
T (site) – Tongue 
